Conference Coverage

Sulforaphane for autism? Maybe

 

Key clinical point: The dietary supplement is showing benefit in an ongoing trial, but there are a lot of pills.

Major finding: The response rate at 30 weeks was 56%.

Study details: A randomized trial involving 50 children with autism.

Disclosures: The U.S. Department of Defense is funding the research. The investigators said they have no relevant disclosures.

Source: Zimmerman A et al. Neurology. 2018 Apr;90(15 Suppl.):N1.002.


 

REPORTING FROM AAN 2018

Other groups are looking into sulforaphane, too – not just for autism, but also for schizophrenia, prostate cancer, and other indications.

The U.S. Department of Defense is funding the research. The investigators said they have no relevant disclosures.

SOURCE: Zimmerman A et al. Neurology. 2018 Apr 22; 90(15 Suppl.):N1.002.

Next Article: